Pluristem Therapeutics CEO Yaky Yanay's 2023 pay jumps 111% to $2.7M
Pluristem Therapeutics reports 2023 executive compensation
By ExecPay News
Published: May 1, 2024
Pluristem Therapeutics reported fiscal year 2023 executive compensation information on May 1, 2024.
In 2023, two executives at Pluristem Therapeutics received on average a compensation package of $1.6M, a 51% increase compared to previous year.
Average pay of disclosed executives at Pluristem Therapeutics
Yaky Yanay, Chief Executive Officer, received $2.7M in total, which increased by 111% compared to 2022. 79% of Yanay's compensation, or $2.2M, was in stock awards. Yanay also received $128K in non-equity incentive plan, $414K in salary, as well as $34K in other compensation.
Chen Franco-Yehuda, Chief Financial Officer, received a compensation package of $375K, which decreased by 38% compared to previous year. 76% of the compensation package, or $284K, was in salary.
Pluristem Therapeutics' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on May 1, 2024.